{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"barth","columns":[{"gene":"","key":"population-abc93a0c26865b489282","label":"Barth syndrome","mondoId":"MONDO:0010543","onsetQualifier":null,"originColumnKey":"MONDO:0010543/OMIM:302060","originalViews":[{"key":"MONDO:0010543/OMIM:302060","label":"Barth syndrome","scopeLabel":"OMIM:302060","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0d27c6b09ff366253e7a2b0f9273d8de2b48192f1dbf2246d8f1e717f2a9b69d","18743221364e9aaba6a1c5ee19700326fa09553822a139aed299f7793890fa8c","18c859c9e19bdaa1746d407001d702ce166462a4977f408499c79134f6ab05d5","23687033e0ba4c2251d43ec0f84775a906aea29dfc42f89288272916b39ea02a","245db397d1720d10d1ba43f3e2c32f3f560b086215777b1b32fa1ca2da7fa483","29b9617973edf7f8cf6c32c4110df02d8fc15321a205503dd97ed151876a22d7","34712c22cb739d28d9601e22ebecab55b672a8d4e1bac0c7daa77515d6cabfcc","374bf838639255617d25d603d8ec66891d56cf2dfa8bb9d167d3d3b42c27ae59","37bd03ce041e46e8fc016167c786c79da61125446a4caaedd77e3ee42253edf6","459e8c8f0894998cc6fab27b927df00f32a8873d5b7ecae1fa79b14b0d0cba1b","4f02ad7788c6c3d3a44316d9fc80b046b0de179120618d29e99301f6cee8c8b5","58c1c1b40ee7d56635f93f1708021b37859bf34b4064b9e10f545c1687553b39","6402cc72b5597bab3973e8612700a618e4e7628a1e241c09101f9954098b83df","68d7015178c76b0eb0072ff4cc187da8884aaa60454a0b8f5b9b27587f067c34","68e4cb2b42cde1a6186dc8deba6216fd968ddcf23109b01eba26f9cc5e67dd44","74fe191407167a85333b9458540f27c3aa9c89e05165139dc29916e2f6e56a86","7f6ca3c0fc16ffafd692daee986fdb58ce2e32576032102773a001db45986289","807b2e02f1cd83d3f038ea250d4bb4bd217d6dae995726c5962e4ef9548082ff","8094552de761f0abe61a4021f9c2382a0d9d96d29fab7df3e1297b415bfc8c87","80ba6964b19feeb6eaa98d3ba92f861000373c75c587507909c91135d3125717","878e4cc814ec6984cd0e39f5102b01d290eeb05e46bce5046d640ac8b1a7cb84","894db90c4b201334d57fc67aa0e9155f0993061691631173e3a2372a8bd62d44","8ab98454308b395bda06b1c08a4fb40d934e4ee49f16959c134766008ad54ef8","8f399e9066f2cc365c027e126027c807d620c69cd36ad550a992370bccf82166","909867107930e3051170a77d55e798449187258f792eed98b28f00cbe9b465e6","96619bf6b24a73b43fbb9430e3cb02f563458f41704fdedbd5418b5216497c76","afc8816b8727184530eaaed01aa35a2fbf967b59eb4ad44b5246f81f6cec481b","c438c94c0981d624b76aef499bd128d84060d6ef7a6c7938fec7e5adb4f6bcf1","c45dcd22992609d1c70fcee5eb2efefe1f04a7c5708fa036209be275849c7f8f","c56642f92f2c98a561946f9a5eba4e768411cc6f444f0a01d43cc49a1c49e5f9","ca14c3138a97f4b8bc4867e0f0e357b15d7e3fc7597db860dd42f38a3fdb1dfe","dbdf4db4b027f15485f0581945fa8e265e909c4b3eaa479eed1a6c3a1510849d","e351e38da6d9664bead3743ad21338696ab1028859237edb0b4ddf4ee1fbb78b","e3629b09cadb6cb4ddfe6f98b1031f52af888c479ea36fe31eb9c9f632b3aa0e","e5ea500a1dbd1cd5d0ab6057c13eaf1656cffb50da29327d265f646188eeecd7","e8322a6d8c7e5d0a7a27b6e9db9cba28f8169fb53c7ffe1a545623151b1d30da","f132d148ecf85e19c6977dca06bc1c4514bc03e3526c2919afb9ad0653056b8c"],"recordQualifiers":{},"scopeLabel":"OMIM:302060","sourceIds":["OMIM:302060"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-60c9abf30026eeb46c7d","label":"Barth syndrome","mondoId":"MONDO:0010543","onsetQualifier":null,"originColumnKey":"MONDO:0010543/ORPHA:111","originalViews":[{"key":"MONDO:0010543/ORPHA:111","label":"Barth syndrome","scopeLabel":"ORPHA:111","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["5bf54fea253243a20f1015c06a7b4a421d1da7a6fba6c8e6b2c2de972adc0612","62190de098aa82c8873132722c13b7ee90df955b02251753a442ee4ff6b2c3cb","85d0067bb97508c01ebad3382e3009fcf2cb4fcd74f34060ff99a38feb58c87c","f78f7847e3cd06aba4d05a09930b8a1b8311add6da748dc5470b596f712facf5"],"recordQualifiers":{},"scopeLabel":"ORPHA:111","sourceIds":["ORPHA:111"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-abc93a0c26865b489282","population-60c9abf30026eeb46c7d"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003535","HP:0008322","HP:0001874","HP:0011675","HP:0000337","HP:0001635","HP:0040289"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":26,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":41,"sourceGroups":{"omim":10,"orphanet":4,"published":27}},"features":[{"hpoId":"HP:0003535","label":"3-Methylglutaconic aciduria","primary":true},{"hpoId":"HP:0008322","label":"Abnormal mitochondrial morphology","primary":true},{"hpoId":"HP:0001874","label":"Abnormality of neutrophils","primary":true},{"hpoId":"HP:0011675","label":"Arrhythmia","primary":true},{"hpoId":"HP:0000337","label":"Broad forehead","primary":true},{"hpoId":"HP:0001635","label":"Congestive heart failure","primary":true},{"hpoId":"HP:0040289","label":"Cyclically decreased total neutrophil count","primary":true},{"hpoId":"HP:0001913","label":"Decreased total granulocyte count","primary":false},{"hpoId":"HP:0001875","label":"Decreased total neutrophil count","primary":false},{"hpoId":"HP:0000490","label":"Deeply set eye","primary":false},{"hpoId":"HP:0001644","label":"Dilated cardiomyopathy","primary":false},{"hpoId":"HP:6000517","label":"Elevated monolysocardiolipin/cardiolipin ratio","primary":false},{"hpoId":"HP:0001706","label":"Endocardial fibroelastosis","primary":false},{"hpoId":"HP:0003546","label":"Exercise intolerance","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0002286","label":"Fair hair","primary":false},{"hpoId":"HP:0012378","label":"Fatigue","primary":false},{"hpoId":"HP:0000293","label":"Full cheeks","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0003391","label":"Gowers sign","primary":false},{"hpoId":"HP:0001510","label":"Growth delay","primary":false},{"hpoId":"HP:0000348","label":"High forehead","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0004840","label":"Hypochromic microcytic anemia","primary":false},{"hpoId":"HP:0033755","label":"Increased left ventricular end-diastolic volume","primary":false},{"hpoId":"HP:0004913","label":"Intermittent lactic acidemia","primary":false},{"hpoId":"HP:0000400","label":"Macrotia","primary":false},{"hpoId":"HP:0000303","label":"Mandibular prognathia","primary":false},{"hpoId":"HP:0001270","label":"Motor delay","primary":false},{"hpoId":"HP:0002058","label":"Myopathic facies","primary":false},{"hpoId":"HP:0000307","label":"Pointed chin","primary":false},{"hpoId":"HP:0002837","label":"Recurrent bronchitis","primary":false},{"hpoId":"HP:0005437","label":"Recurrent infections in infancy and early childhood","primary":false},{"hpoId":"HP:0000311","label":"Round face","primary":false},{"hpoId":"HP:0003756","label":"Skeletal myopathy","primary":false},{"hpoId":"HP:0001762","label":"Talipes equinovarus","primary":false},{"hpoId":"HP:0005180","label":"Tricuspid regurgitation","primary":false}],"ledeHtml":"Barth syndrome is a rare condition characterized by an enlarged and weakened heart (dilated cardiomyopathy), weakness in muscles used for movement (skeletal myopathy), recurrent infections due to small numbers of white blood cells (neutropenia), and short stature. Barth syndrome occurs almost exclusively in males.","mondoId":"MONDO:0010543","node":{"canonicalSlug":"barth","comparisons":[{"documentSha256":"5e7e7c0a97200d46d7e769c9349a7f5f1b22314d1b64b2b4cc81e4e1676a91b8","key":"legacy-barth","kind":"legacy","label":"Barth syndrome","memberIds":["MONDO:0010543"],"mondoId":"MONDO:0010543","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/barth.5e7e7c0a97200d46d7e769c9349a7f5f1b22314d1b64b2b4cc81e4e1676a91b8.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":["Mutations in the TAFAZZIN gene cause Barth syndrome. The TAFAZZIN gene provides instructions for making a protein called tafazzin. This protein is located in structures called mitochondria, which are the energy-producing centers of cells. The tafazzin protein is involved in altering a fat (lipid) called cardiolipin, which plays critical roles in the mitochondrial inner membrane. Once altered by tafazzin, cardiolipin is key in maintaining mitochondrial shape, energy production, and protein transport within cells.","TAFAZZIN gene mutations result in the production of tafazzin proteins with little or no function. As a result, tafazzin cannot alter cardiolipin, and levels of functional cardiolipin are reduced. In addition, for unknown reasons, a variant of cardiolipin called monolysocardiolipin (MLCL) is formed. A lack of functional cardiolipin and an excess of MLCL are thought to impair normal mitochondrial shape and functions. Tissues with high energy demands, such as the heart and skeletal muscles, are most susceptible to cell death due to reduced energy production in mitochondria. Additionally, abnormally shaped mitochondria are found in affected white blood cells, which could affect their ability to grow (proliferate), mature (differentiate), and function, leading to neutropenia. Dysfunctional mitochondria likely lead to other signs and symptoms of Barth syndrome."],"causesUrl":"https://medlineplus.gov/genetics/condition/barth-syndrome/#causes","contentForm":"summary","matchMethod":"automatic-preferred-name","name":"Barth syndrome","paragraphs":["Barth syndrome is a rare condition characterized by an enlarged and weakened heart (dilated cardiomyopathy), weakness in muscles used for movement (skeletal myopathy), recurrent infections due to small numbers of white blood cells (neutropenia), and short stature. Barth syndrome occurs almost exclusively in males.","In males with Barth syndrome, dilated cardiomyopathy is often present at birth or develops within the first months of life. Over time, the heart muscle becomes increasingly weakened and is less able to pump blood. Individuals with Barth syndrome may have elastic fibers in place of muscle fibers in some areas of the heart muscle, which contributes to the cardiomyopathy. This condition is called endocardial fibroelastosis; it results in thickening of the muscle and impairs its ability to pump blood. In people with Barth syndrome, the heart problems can lead to heart failure. In rare cases, the cardiomyopathy gets better over time and affected individuals eventually have no symptoms of heart disease.","In Barth syndrome, skeletal myopathy, particularly of the muscles closest to the center of the body (proximal muscles), is usually noticeable from birth and causes low muscle tone (hypotonia). The muscle weakness often causes delay of motor skills such as crawling and walking. Additionally, affected individuals tend to experience extreme tiredness (fatigue) during strenuous physical activity.","Most males with Barth syndrome have neutropenia. The levels of white blood cells can be consistently low (persistent), can vary from normal to low (intermittent), or can cycle between regular episodes of normal and low (cyclical). Neutropenia makes it more difficult for the body to fight off foreign invaders such as bacteria and viruses, so affected individuals have an increased risk of recurrent infections.","Newborns with Barth syndrome are often smaller than normal, and their growth continues to be slow throughout life. Some boys with this condition experience a growth spurt in puberty and are of average height as adults, but many men with Barth syndrome continue to have short stature in adulthood.","Males with Barth syndrome often have distinctive facial features including prominent cheeks. Affected individuals typically have normal intelligence but often have difficulty performing tasks involving math or visual-spatial skills such as puzzles.","Males with Barth syndrome have increased levels of a substance called 3-methylglutaconic acid in their blood and urine. The amount of the acid does not appear to influence the signs and symptoms of the condition. Barth syndrome is one of a group of metabolic disorders that can be diagnosed by the presence of increased levels of 3-methylglutaconic acid in urine (3-methylglutaconic aciduria).","Even though most features of Barth syndrome are present at birth or in infancy, affected individuals may not experience health problems until later in life. The age at which individuals with Barth syndrome display symptoms or are diagnosed varies greatly. The severity of signs and symptoms among affected individuals is also highly variable.","Males with Barth syndrome have a reduced life expectancy. Many affected children die of heart failure or infection in infancy or early childhood, but those who live into adulthood can survive into their late forties."],"reviewed":"2014-07","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/barth-syndrome"},"ownColumnKeys":["population-abc93a0c26865b489282","population-60c9abf30026eeb46c7d"],"publication":"published","relationships":[{"kind":"parent","label":"inborn mitochondrial myopathy","mondoId":"MONDO:0009637","slug":null},{"kind":"parent","label":"constitutional neutropenia","mondoId":"MONDO:0015134","slug":"constitutional-neutropenia"},{"kind":"parent","label":"syndromic dyslipidemia","mondoId":"MONDO:0015905","slug":null},{"kind":"parent","label":"familial dilated cardiomyopathy","mondoId":"MONDO:0016333","slug":"familial-dilated-cardiomyopathy"},{"kind":"parent","label":"3-methylglutaconic aciduria","mondoId":"MONDO:0017359","slug":"3-methylglutaconic-aciduria"},{"kind":"parent","label":"disorder of phospholipids, sphingolipids and fatty acids biosynthesis","mondoId":"MONDO:0018117","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending","articles":[{"articleId":"www.ncbi.nlm.nih.gov/books/NBK247162","pageMondoId":"MONDO:0010543","source":"GeneReviews","name":"Barth Syndrome","url":"https://www.ncbi.nlm.nih.gov/books/NBK247162/","relationToPage":"same-condition","coveredMondoIds":["MONDO:0010543"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-preferred-title"],"reviewed":"2026-01-08","sourceRelease":"2026-10-18 12:08:12.262034+00","upstream":"GeneReviews clinical characteristics","rawAttribution":null,"independentCorroborationEstablished":false},{"articleId":"rarediseases.info.nih.gov/diseases/5890","pageMondoId":"MONDO:0010543","source":"GARD","name":"3-Methylglutaconic aciduria type 2","url":"https://rarediseases.info.nih.gov/diseases/5890","relationToPage":"same-condition","coveredMondoIds":["MONDO:0010543"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-21T17:05:39Z","upstream":"GARD:0005890","rawAttribution":"MONDO:0010543","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"reported","key":"0d27c6b09ff366253e7a2b0f9273d8de2b48192f1dbf2246d8f1e717f2a9b69d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004913","is_excluded":false,"label":"Intermittent lactic acidemia","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"18743221364e9aaba6a1c5ee19700326fa09553822a139aed299f7793890fa8c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"2/5","hpo_id":"HP:0003756","is_excluded":false,"label":"Skeletal myopathy","onset_id":null,"reference":"PMID:10484795","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"18c859c9e19bdaa1746d407001d702ce166462a4977f408499c79134f6ab05d5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0003391","is_excluded":false,"label":"Gowers sign","onset_id":null,"reference":"PMID:10484795","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"23687033e0ba4c2251d43ec0f84775a906aea29dfc42f89288272916b39ea02a","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"PMID:10484795","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"245db397d1720d10d1ba43f3e2c32f3f560b086215777b1b32fa1ca2da7fa483","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000293","is_excluded":false,"label":"Full cheeks","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"29b9617973edf7f8cf6c32c4110df02d8fc15321a205503dd97ed151876a22d7","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000307","is_excluded":false,"label":"Pointed chin","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"34712c22cb739d28d9601e22ebecab55b672a8d4e1bac0c7daa77515d6cabfcc","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000337","is_excluded":false,"label":"Broad forehead","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"374bf838639255617d25d603d8ec66891d56cf2dfa8bb9d167d3d3b42c27ae59","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001762","is_excluded":false,"label":"Talipes equinovarus","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"37bd03ce041e46e8fc016167c786c79da61125446a4caaedd77e3ee42253edf6","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001875","is_excluded":false,"label":"Decreased total neutrophil count","onset_id":null,"reference":"PMID:10484795","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"459e8c8f0894998cc6fab27b927df00f32a8873d5b7ecae1fa79b14b0d0cba1b","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000348","is_excluded":false,"label":"High forehead","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4f02ad7788c6c3d3a44316d9fc80b046b0de179120618d29e99301f6cee8c8b5","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002286","is_excluded":false,"label":"Fair hair","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"58c1c1b40ee7d56635f93f1708021b37859bf34b4064b9e10f545c1687553b39","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"5bf54fea253243a20f1015c06a7b4a421d1da7a6fba6c8e6b2c2de972adc0612","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:111","disease_name":"Barth syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008322","is_excluded":false,"label":"Abnormal mitochondrial morphology","onset_id":null,"reference":"ORPHA:111","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"62190de098aa82c8873132722c13b7ee90df955b02251753a442ee4ff6b2c3cb","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:111","disease_name":"Barth syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001706","is_excluded":false,"label":"Endocardial fibroelastosis","onset_id":null,"reference":"ORPHA:111","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6402cc72b5597bab3973e8612700a618e4e7628a1e241c09101f9954098b83df","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"68d7015178c76b0eb0072ff4cc187da8884aaa60454a0b8f5b9b27587f067c34","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000303","is_excluded":false,"label":"Mandibular prognathia","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"68e4cb2b42cde1a6186dc8deba6216fd968ddcf23109b01eba26f9cc5e67dd44","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:10484795","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"74fe191407167a85333b9458540f27c3aa9c89e05165139dc29916e2f6e56a86","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000400","is_excluded":false,"label":"Macrotia","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7f6ca3c0fc16ffafd692daee986fdb58ce2e32576032102773a001db45986289","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"807b2e02f1cd83d3f038ea250d4bb4bd217d6dae995726c5962e4ef9548082ff","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:6000517","is_excluded":false,"label":"Elevated monolysocardiolipin/cardiolipin ratio","onset_id":null,"reference":"PMID:34382226","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8094552de761f0abe61a4021f9c2382a0d9d96d29fab7df3e1297b415bfc8c87","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000311","is_excluded":false,"label":"Round face","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"80ba6964b19feeb6eaa98d3ba92f861000373c75c587507909c91135d3125717","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011675","is_excluded":false,"label":"Arrhythmia","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"85d0067bb97508c01ebad3382e3009fcf2cb4fcd74f34060ff99a38feb58c87c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:111","disease_name":"Barth syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001874","is_excluded":false,"label":"Abnormality of neutrophils","onset_id":null,"reference":"ORPHA:111","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"878e4cc814ec6984cd0e39f5102b01d290eeb05e46bce5046d640ac8b1a7cb84","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0005180","is_excluded":false,"label":"Tricuspid regurgitation","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"894db90c4b201334d57fc67aa0e9155f0993061691631173e3a2372a8bd62d44","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0002058","is_excluded":false,"label":"Myopathic facies","onset_id":null,"reference":"PMID:10484795","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8ab98454308b395bda06b1c08a4fb40d934e4ee49f16959c134766008ad54ef8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0003535","is_excluded":false,"label":"3-Methylglutaconic aciduria","onset_id":null,"reference":"PMID:10484795","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8f399e9066f2cc365c027e126027c807d620c69cd36ad550a992370bccf82166","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001913","is_excluded":false,"label":"Decreased total granulocyte count","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"909867107930e3051170a77d55e798449187258f792eed98b28f00cbe9b465e6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001635","is_excluded":false,"label":"Congestive heart failure","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"96619bf6b24a73b43fbb9430e3cb02f563458f41704fdedbd5418b5216497c76","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001644","is_excluded":false,"label":"Dilated cardiomyopathy","onset_id":null,"reference":"PMID:10484795","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"afc8816b8727184530eaaed01aa35a2fbf967b59eb4ad44b5246f81f6cec481b","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0004840","is_excluded":false,"label":"Hypochromic microcytic anemia","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c438c94c0981d624b76aef499bd128d84060d6ef7a6c7938fec7e5adb4f6bcf1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008322","is_excluded":false,"label":"Abnormal mitochondrial morphology","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"c45dcd22992609d1c70fcee5eb2efefe1f04a7c5708fa036209be275849c7f8f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0040289","is_excluded":false,"label":"Cyclically decreased total neutrophil count","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c56642f92f2c98a561946f9a5eba4e768411cc6f444f0a01d43cc49a1c49e5f9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001270","is_excluded":false,"label":"Motor delay","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ca14c3138a97f4b8bc4867e0f0e357b15d7e3fc7597db860dd42f38a3fdb1dfe","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000490","is_excluded":false,"label":"Deeply set eye","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"dbdf4db4b027f15485f0581945fa8e265e909c4b3eaa479eed1a6c3a1510849d","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0005437","is_excluded":false,"label":"Recurrent infections in infancy and early childhood","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e351e38da6d9664bead3743ad21338696ab1028859237edb0b4ddf4ee1fbb78b","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e3629b09cadb6cb4ddfe6f98b1031f52af888c479ea36fe31eb9c9f632b3aa0e","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0033755","is_excluded":false,"label":"Increased left ventricular end-diastolic volume","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e5ea500a1dbd1cd5d0ab6057c13eaf1656cffb50da29327d265f646188eeecd7","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001706","is_excluded":false,"label":"Endocardial fibroelastosis","onset_id":null,"reference":"OMIM:302060","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e8322a6d8c7e5d0a7a27b6e9db9cba28f8169fb53c7ffe1a545623151b1d30da","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002837","is_excluded":false,"label":"Recurrent bronchitis","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f132d148ecf85e19c6977dca06bc1c4514bc03e3526c2919afb9ad0653056b8c","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:302060","disease_name":"Barth syndrome","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003546","is_excluded":false,"label":"Exercise intolerance","onset_id":null,"reference":"PMID:34355125","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f78f7847e3cd06aba4d05a09930b8a1b8311add6da748dc5470b596f712facf5","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:111","disease_name":"Barth syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001644","is_excluded":false,"label":"Dilated cardiomyopathy","onset_id":null,"reference":"ORPHA:111","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/barth-syndrome\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK247162/\" rel=\"noreferrer\">GeneReviews</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/5890\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0010543\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-name</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Barth syndrome is a rare condition characterized by an enlarged and weakened heart (dilated cardiomyopathy), weakness in muscles used for movement (skeletal myopathy), recurrent infections due to small numbers of white blood cells (neutropenia), and short stature. Barth syndrome occurs almost exclusively in males.</p><p>In males with Barth syndrome, dilated cardiomyopathy is often present at birth or develops within the first months of life. Over time, the heart muscle becomes increasingly weakened and is less able to pump blood. Individuals with Barth syndrome may have elastic fibers in place of muscle fibers in some areas of the heart muscle, which contributes to the cardiomyopathy. This condition is called endocardial fibroelastosis; it results in thickening of the muscle and impairs its ability to pump blood. In people with Barth syndrome, the heart problems can lead to heart failure. In rare cases, the cardiomyopathy gets better over time and affected individuals eventually have no symptoms of heart disease.</p><p>In Barth syndrome, skeletal myopathy, particularly of the muscles closest to the center of the body (proximal muscles), is usually noticeable from birth and causes low muscle tone (hypotonia). The muscle weakness often causes delay of motor skills such as crawling and walking. Additionally, affected individuals tend to experience extreme tiredness (fatigue) during strenuous physical activity.</p><p>Most males with Barth syndrome have neutropenia. The levels of white blood cells can be consistently low (persistent), can vary from normal to low (intermittent), or can cycle between regular episodes of normal and low (cyclical). Neutropenia makes it more difficult for the body to fight off foreign invaders such as bacteria and viruses, so affected individuals have an increased risk of recurrent infections.</p><p>Newborns with Barth syndrome are often smaller than normal, and their growth continues to be slow throughout life. Some boys with this condition experience a growth spurt in puberty and are of average height as adults, but many men with Barth syndrome continue to have short stature in adulthood.</p><p>Males with Barth syndrome often have distinctive facial features including prominent cheeks. Affected individuals typically have normal intelligence but often have difficulty performing tasks involving math or visual-spatial skills such as puzzles.</p><p>Males with Barth syndrome have increased levels of a substance called 3-methylglutaconic acid in their blood and urine. The amount of the acid does not appear to influence the signs and symptoms of the condition. Barth syndrome is one of a group of metabolic disorders that can be diagnosed by the presence of increased levels of 3-methylglutaconic acid in urine (3-methylglutaconic aciduria).</p><p>Even though most features of Barth syndrome are present at birth or in infancy, affected individuals may not experience health problems until later in life. The age at which individuals with Barth syndrome display symptoms or are diagnosed varies greatly. The severity of signs and symptoms among affected individuals is also highly variable.</p><p>Males with Barth syndrome have a reduced life expectancy. Many affected children die of heart failure or infection in infancy or early childhood, but those who live into adulthood can survive into their late forties.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/barth-syndrome\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>Mutations in the TAFAZZIN gene cause Barth syndrome. The TAFAZZIN gene provides instructions for making a protein called tafazzin. This protein is located in structures called mitochondria, which are the energy-producing centers of cells. The tafazzin protein is involved in altering a fat (lipid) called cardiolipin, which plays critical roles in the mitochondrial inner membrane. Once altered by tafazzin, cardiolipin is key in maintaining mitochondrial shape, energy production, and protein transport within cells.</p><p>TAFAZZIN gene mutations result in the production of tafazzin proteins with little or no function. As a result, tafazzin cannot alter cardiolipin, and levels of functional cardiolipin are reduced. In addition, for unknown reasons, a variant of cardiolipin called monolysocardiolipin (MLCL) is formed. A lack of functional cardiolipin and an excess of MLCL are thought to impair normal mitochondrial shape and functions. Tissues with high energy demands, such as the heart and skeletal muscles, are most susceptible to cell death due to reduced energy production in mitochondria. Additionally, abnormally shaped mitochondria are found in affected white blood cells, which could affect their ability to grow (proliferate), mature (differentiate), and function, leading to neutropenia. Dysfunctional mitochondria likely lead to other signs and symptoms of Barth syndrome.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/barth-syndrome/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"barth","sourceDocuments":[{"name":"MedlinePlus: Barth syndrome","reviewed":"2014-07","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/barth-syndrome"},{"name":"GeneReviews: Barth Syndrome","reviewed":"2026-01-08","source_release":"2026-10-18 12:08:12.262034+00","url":"https://www.ncbi.nlm.nih.gov/books/NBK247162/"},{"name":"GARD: 3-Methylglutaconic aciduria type 2","reviewed":null,"source_release":"2026-10-21T17:05:39Z","url":"https://rarediseases.info.nih.gov/diseases/5890"},{"name":"MONDO: Barth syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0010543"}],"sourceNote":"","synonyms":["3-methylglutaconic aciduria type 2","3-methylglutaconic aciduria type II","Barth syndrome","BTHS","cardioskeletal myopathy with neutropenia and abnormal mitochondria","cardioskeletal myopathy-neutropenia syndrome","MGA2","TAZ defect","X-linked cardioskeletal myopathy and neutropenia"],"takeawayHtml":"","title":"Barth syndrome"},"schemaVersion":1}
